Companies / Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.

Nasdaq: CRVSCIK 1626971SOUTH SAN FRANCISCO, CA

Financials

Revenue
Net income$-15.28M
Total debt
Cash$18.91M
Diluted EPS$-0.53
Shares outstanding84.1M

Ownership

84.1M shares outstanding · as of Aug 6, 2026
1.7%Insiders
Ownership
Insiders1.67%1,405,035
10%+ / strategic5.32%4,474,091
Institutions61.62%51,833,584
Public float31.39%26,408,234

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 3

View all →
Insider% of sharesShares
Miller Richard a MdCEOPresident and CEO · Director
1.42%1,195,035
Thompson Peter A.Director · 10% owner
0.25%210,000
Clark Ian TDirector

Institutional holders 141

View all →
HolderValue% of shares
BlackRock, Inc.$106.65M8.49%
Orbimed Advisors LLC$104.82M8.52%
State Street Corporation$66.84M5.32%
Adams Street Partners LLC$47.92M3.89%
Perceptive Advisors LLC$33.54M2.73%
Vanguard Group Inc$29.83M4.60%
Morgan Stanley$27.47M4.24%
Geode Capital Management, LLC$25.06M2.04%
Point72 Asset Management, L.P.$22.14M3.42%
MPM BioImpact LLC$21.13M3.26%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$450.0K+30K
30,000
0.04% of shares
low
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$187.5K+15K
+33.33%
60,000
0.07% of shares
low
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$145.5K+15K
+50.00%
45,000
0.05% of shares
low
May 18, 2026Miller Richard a Md
CEO
BuyCommon Stock$60.3K+5K
+0.42%
1,193,103
1.42% of shares
medium
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$54.1K+15K
+25.00%
75,000
0.09% of shares
low
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$49.0K+15K
+16.67%
105,000
0.12% of shares
low
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$41.1K+15K
+14.29%
120,000
0.14% of shares
low
Jan 28, 2026Thompson Peter A.
Director
ExerciseCommon Stock$39.0K+15K
+12.50%
135,000
0.16% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G4,474,091
Vanguard Group IncPassive13G/A0
Vanguard Group IncPassive13G3,873,482
Miller Richard a MdPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CRVS221015100